A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province
1 other identifier
observational
1,340
1 country
1
Brief Summary
Through a multicenter case-control study on the risk factors of premature ejaculation in Shaanxi, to find out the related factors of the occurrence and development of premature ejaculation, to provide reference for personalized treatment, in order to improve the quality of sexual life of patients and partners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 31, 2019
CompletedFirst Submitted
Initial submission to the registry
January 15, 2020
CompletedFirst Posted
Study publicly available on registry
January 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedJanuary 21, 2020
January 1, 2020
1.1 years
January 15, 2020
January 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IELT
Intra-vaginal Ejaculation Latency Time
Within 6 months
Eligibility Criteria
Patients with premature ejaculation in the outpatient department of the hospital were the case group, while patients without premature ejaculation in the outpatient department were the control group
You may qualify if:
- \) case group
- years old, regular sexual life \> 6 months;
- Self-report of premature ejaculation;
- Able to complete questionnaires and scale scores independently. 2) control group
- <!-- -->
- years old, regular sexual life \> 6 months;
- Both partners are satisfied with their sexual life;
- Able to complete questionnaires and scale scores independently.
You may not qualify if:
- \) case group
- Those who are unable to have sex due to genital malformation;
- Patients with serious cardiovascular and cerebrovascular diseases;
- Severe mental disorders (history of epilepsy, mania, etc.);
- Have a history of brain trauma;
- People with a long history of substance abuse. 2) control group
- <!-- -->
- Patients with a history of mental illness;
- Oral selective serotonin (5-ht) reuptake inhibitors, tricyclic antidepressants, triazolidine antidepressants, tramadol and sedatives
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
- First Affiliated Hospital Xi'an Jiaotong Universitycollaborator
- Shaanxi Provincial People's Hospitalcollaborator
- Xi'an No.3 Hospitalcollaborator
- Shaanxi Armed Police Corps Hospitalcollaborator
- Northwest Women's and Children's Hospital, Xi'an, Shaanxicollaborator
Study Sites (1)
Xijing Hospital, Fourth Military Medical University
Xi'an, Shaanxi, 710032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2020
First Posted
January 21, 2020
Study Start
July 31, 2019
Primary Completion
August 31, 2020
Study Completion
October 1, 2020
Last Updated
January 21, 2020
Record last verified: 2020-01